patent/PE-20000560-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20000560-A1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-642 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
filingDate	1999-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_888f1ca5043fcc1c199093ddb071048f
publicationDate	2000-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	PE-20000560-A1
titleOfInvention	USE OF PEG-IFN-ALPHA AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C
abstract	IT REFERS TO THE USE OF CONJUGATES OF POLYETHYLENE GLYCOL-INTERFERON IN ASSOCIATION WITH RIBAVIRIN, WHICH PREFERENCE INCLUDES: a) PEG-IFN-O OF FORMULA I, WHERE RYR` ARE METHYL, X IS NH, n AND n 'ARE 420 OR 520, USING FROM 33 µg TO 540 µg PER WEEK FOR PREFERENCE TREATING AN INTERFERON ALPHA 2A DERIVATIVE; b) RIBAVIRIN USING 400 mg TO 1200 mg DAILY. INTERFERON IS A PROTEIN THAT HAS ANTITIVIRIC, ANTIPROLIFERATIVE AND IMMUNOREGULATORY ACTIVITY SO THE COMPOSITION MAY BE USEFUL FOR THE TREATMENT OF CHRONIC HEPATITIS C
priorityDate	1998-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID515951 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507729

Total number of triples: 28.